These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Current trends in diagnosis and management of cardiac amyloidosis. Esplin BL, Gertz MA. Curr Probl Cardiol; 2013 Feb; 38(2):53-96. PubMed ID: 23337445 [Abstract] [Full Text] [Related]
6. Cardiac manifestations of amyloid disease. Rivera RJ, Vicenty S. Bol Asoc Med P R; 2008 Feb; 100(4):60-70. PubMed ID: 19400531 [Abstract] [Full Text] [Related]
7. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know]. Arbustini E, Gavazzi A, Merlini G. Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807 [Abstract] [Full Text] [Related]
9. Heart transplantation in systemic (AL) amyloidosis: a retrospective study of eight French patients. Mignot A, Varnous S, Redonnet M, Jaccard A, Epailly E, Vermes E, Boissonnat P, Gandjbakhch I, Herpin D, Touchard G, Bridoux F. Arch Cardiovasc Dis; 2008 Sep; 101(9):523-32. PubMed ID: 19041836 [Abstract] [Full Text] [Related]
12. Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis. Sack FU, Kristen A, Goldschmidt H, Schnabel PA, Dengler T, Koch A, Karck M. Eur J Cardiothorac Surg; 2008 Feb; 33(2):257-62. PubMed ID: 18096396 [Abstract] [Full Text] [Related]
18. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study. Perz JB, Schonland SO, Hundemer M, Kristen AV, Dengler TJ, Zeier M, Linke RP, Ho AD, Goldschmidt H. Br J Haematol; 2004 Dec 26; 127(5):543-51. PubMed ID: 15566357 [Abstract] [Full Text] [Related]
19. Case report: isolated cardiac amyloidosis: an enigma unravelled. Khalid U, Awar O, Verstovsek G, Cheong B, Yellapragada SV, Jneid H, Deswal A, Virani SS. Methodist Debakey Cardiovasc J; 2015 Dec 26; 11(1):53-8. PubMed ID: 25793032 [Abstract] [Full Text] [Related]
20. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Quarta CC, Solomon SD, Uraizee I, Kruger J, Longhi S, Ferlito M, Gagliardi C, Milandri A, Rapezzi C, Falk RH. Circulation; 2014 May 06; 129(18):1840-9. PubMed ID: 24563469 [Abstract] [Full Text] [Related] Page: [Next] [New Search]